EUVIMEDEUVIMED entdecken
Crossref

Inhibition of Lysosomal Cathepsin A and Neuraminidase 1 Interaction by Anti‐Obesity Cyclic Peptide

Yiting Sun, Ayumi Dakiiwa, Menghua Zhang, Takahiro Shibata, Masaki Kita iD

Chemistry – A European Journal · 2024

DOI: 10.1002/chem.202402049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – A European Journal, 2024. Verfasst von Yiting Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Bioagricultural Sciences, Nagoya University, Furo-cho, Chikusa, Nagoya, 464-8601, Japan. Hauptthemen laut MEDLINE: Neuraminidase, Peptides, Cyclic, Molecular Docking Simulation, Cathepsin A. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Astellas Foundation for Research on Metabolic Disorders, Naito Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic inflammation in adipose tissue is associated with metabolic disorders such as obesity and type 2 diabetes. Novel small molecules targeting adipocyte differentiation and fat accumulation offer potential for new anti‐inflammatory and anti‐obesity drugs. Here we show that the marine cyclic heptapeptide stylissatin A and its analogs (SAs) inhibit membranous neuraminidase 1 (Neu1) function by interacting with lysosomal protective protein cathepsin A (PPCA). Neu1 has been less explored as a therapeutic target due to the genetic defects leading to neurodegenerative disorders. However, unlike traditional neuraminidase inhibitors, SAs don't directly bind to Neu1 but modulate the molecular chaperone activity of PPCA. SAs caused degradation of perilipin 1 around lipid droplets and inhibited fat accumulation, along with decrease in membranous Neu1. Molecular docking and molecular dynamics simulations revealed that SAs interacted with activated PPCA at the Neu1 binding site. Focusing on this newfound protein–protein interaction inhibition mechanism could lead to the development of pharmaceuticals with fewer side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuraminidasePeptides, CyclicMolecular Docking SimulationCathepsin AMolecular Dynamics SimulationHumansLysosomesAnti-Obesity AgentsAnimalsBinding SitesMiceProtein Binding

Stichwörter der Autor:innen

Bioactive natural productsChemical probeMolecular dynamics simulationPPI inhibitorProtective protein cathepsin A

Substanzen

NeuraminidasePeptides, CyclicCathepsin AAnti-Obesity Agents

Autor:innen und Institutionen

  • Graduate School of Bioagricultural Sciences, Nagoya University, Furo-cho, Chikusa, Nagoya, 464-8601, Japan.

ORCID-Profile: Masaki Kita

Förderung

  • Japan Society for the Promotion of Science
  • Astellas Foundation for Research on Metabolic Disorders
  • Naito Foundation

Zitieren

APA

Sun, Y., Dakiiwa, A., Zhang, M., Shibata, T., & Kita, M. (2024). Inhibition of Lysosomal Cathepsin A and Neuraminidase 1 Interaction by Anti‐Obesity Cyclic Peptide. Chemistry – A European Journal. https://doi.org/10.1002/chem.202402049

Vancouver

Sun Y, Dakiiwa A, Zhang M, Shibata T, Kita M. Inhibition of Lysosomal Cathepsin A and Neuraminidase 1 Interaction by Anti‐Obesity Cyclic Peptide. Chemistry – A European Journal. 2024. doi:10.1002/chem.202402049

BibTeX
@article{Sun2024,
  author = {Sun, Yiting and Dakiiwa, Ayumi and Zhang, Menghua and Shibata, Takahiro and Kita, Masaki},
  title = {Inhibition of Lysosomal Cathepsin A and Neuraminidase 1 Interaction by Anti‐Obesity Cyclic Peptide},
  journal = {Chemistry – A European Journal},
  year = {2024},
  doi = {10.1002/chem.202402049}
}
Kostenlos starten →